| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $533.1M | +6.4% |
| Cost of Revenue | $296.0M | +6.6% |
| Gross Profit | $237.1M | +6.2% |
| R&D Expense | $42.8M | +3.7% |
| SG&A Expense | $69.8M | +8.5% |
| Operating Income | $25.1M | +26.1% |
| Pre-tax Income | $31.1M | +25.9% |
| Income Tax | $9.8M | +21.6% |
| Net Income | $21.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.8M | +24.4% |
| Short-term Investments | $17.3M | +23.4% |
| Accounts Receivable | $79.0M | +18.7% |
| Inventory | $14.4M | +17.0% |
| Current Assets | $233.5M | +19.9% |
| Total Assets | $763.4M | +2.7% |
| Current Liabilities | $67.0M | +25.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.5M | -4.3% |
| Capital Expenditures | $14.8M | +61.9% |
| Investing Cash Flow | -$13.4M | +1.3% |
| Financing Cash Flow | -$40.4M | +31.1% |
| Free Cash Flow | $59.7M | -13.1% |
| +28.0% |
| EPS (Basic) | $0.89 | +34.8% |
| EPS (Diluted) | $0.88 | +33.3% |
| Total Liabilities |
| $89.5M |
| +22.0% |
| Stockholders' Equity | $673.9M | +0.6% |